Education
About Us
Working with TipRanks
Follow Us
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
CDT Stock Chart & Stats
$1.63
-$0.01(-12.77%)
At close: 4:00 PM EST
$1.63
-$0.01(-12.77%)
Day’s Range― - ―
52-Week Range$1.48 - $2,201.35
Previous Close$0.08
Volume254.55M
Average Volume (3M)96.60K
Market Cap
$2.79M
Enterprise ValueN/A
Total Cash (Recent Filing)$4.83M
Total Debt (Recent Filing)$1.88M
Price to Earnings (P/E)―
Beta1.67
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.28
Shares Outstanding1,629,402
10 Day Avg. Volume40,230
30 Day Avg. Volume96,602
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)-246.57
Price to Sales (P/S)0.00
P/FCF Ratio-172.09
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Conduit Pharmaceuticals News
CDT FAQ
What was Conduit Pharmaceuticals’s price range in the past 12 months?
Conduit Pharmaceuticals lowest stock price was $1.48 and its highest was $2201.35 in the past 12 months.
What is Conduit Pharmaceuticals’s market cap?
Conduit Pharmaceuticals’s market cap is $2.79M.
When is Conduit Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Conduit Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Conduit Pharmaceuticals overvalued?
According to Wall Street analysts Conduit Pharmaceuticals’s price is currently Overvalued.
Does Conduit Pharmaceuticals pay dividends?
Conduit Pharmaceuticals does not currently pay dividends.
What is Conduit Pharmaceuticals’s EPS estimate?
Conduit Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Conduit Pharmaceuticals have?
Conduit Pharmaceuticals has 1,629,402 shares outstanding.
What happened to Conduit Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Conduit Pharmaceuticals?
Currently, no hedge funds are holding shares in CDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Conduit Pharmaceuticals
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Technical Analysis
Matinas BioPharma
―
Quoin Pharmaceuticals
―
Silo Pharma
―
CNS Pharmaceuticals
―
Galecto
―